The Asia Pacific alopecia treatment market is estimated to be valued at US$ 2,665.9 Mn

According to the latest market report published by Persistence Market Research, titled "Asia Pacific Alopecia Treatment Market: Industry Analysis and Forecast (2016-2024)", revenue from the Asia Pacific alopecia treatment market is expected to expand at a CAGR of 6.6% during the forecast period 2016 - 2024.

The Asia Pacific alopecia treatment market is expected to grow significantly in the coming years due to increasing awareness about alopecia and the availability of various treatment options. Alopecia is a condition that causes hair loss, and it can affect individuals of all ages and genders. The most common types of alopecia are androgenetic alopecia (AGA) and alopecia areata (AA).

The market for alopecia treatment in the Asia Pacific region is driven by a number of factors, including the increasing prevalence of alopecia, the growing awareness about the condition and its treatment options, and the availability of various treatment options such as medications, topical products, and hair transplantation. In addition, the rising demand for cosmetic procedures and the increasing disposable incomes of individuals in the region are also contributing to the growth of the alopecia treatment market.

Get Going With Sample Of Asia Pacific Alopecia Treatment Market Report! https://www.persistencemarketresearch.com/samples/11077

Key Players

Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Johnson & Johnson, Inc.
Reddy's Laboratories Ltd.
Cipla Ltd.
Cellmid Ltd.
The Himalaya Drug Company
Taisho Pharmaceutical Holdings Co., Ltd
Shiseido Co., Ltd.
Zhangguang 101 Science & Technology Co., Ltd

How About Re-Inventing The Methodical Wheel In The Asia Pacific Alopecia Treatment Market? Switch Over To The "Methodology" Tab! https://www.persistencemarketresearch.com/methodology/11077

By end user segment, the market has been segmented into hospitals, dermatology and trichology clinics, home care settings, and aesthetic clinics. In the overall market, oral solid dosage formulations are expected to witness increased acceptance owing to ease of consumption by patients in Asia Pacific. Accordingly, oral drugs segment is anticipated to witness an increase in value from US$ 556.6 Mn in 2016 to US$ 1,005.1 Mn by the end of 2024.

Rising global demand for effective hair loss treatment medications especially oral drugs is the prime driver of the market. Oral hair loss treatment drugs are gaining popularity as they help in maintaining patient-safety through reduced number of medicine dosages, but with increased drug efficacy.

However, changing lifestyle along with the increase in stress level among working class population, cosmeceutical drug manufacturers focusing on expanding their hair treatment and scalp treatment product line, and cytokine therapy gaining momentum for alopecia treatment are other factors that expected to fuel the market growth for alopecia treatment market over the forecast period.

Patent expiry of major blockbuster drugs resulting in market exclusivity for some brands and various side effects associated with the hair loss treatments is expected to hamper the overall market growth. Some of the side effects such as allergies, depression, and chances of permanent sexual dysfunctions. Other market deterrents include the limited efficacy of the hair loss treatment drugs and lack of reimbursement facilities for hair loss treatments services, such as laser treatments.

Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/11077

Based on countries, the market has been divided into China, Japan, Australia & New Zealand, Malaysia, Singapore, India, Vietnam, Philippines and Rest of Asia-Pacific. Developed pharmaceuticals markets such as the China and Japan are expected to emerge as the main sourcing markets.

This report assesses trends by type of alopecia, treatment type, end user, and countries; to offer analytical insights about the potential demand emerging for particular alopecia treatments in specific regions. China is estimated to dominate the alopecia treatment market accounting for maximum revenue share of the overall market by end of 2016.

By 2024 end, China and Japan markets are expected to account for over three-fifth share of the Asia Pacific alopecia treatment market revenue. In terms of market share by value, China is estimated to retain its dominant position, registering a CAGR of 7.1% over the forecast period.

Related Reports:

Telemedicine Market
https://www.persistencemarketresearch.com/market-research/telemedicine-market.asp

Robotic Surgery Market
https://www.persistencemarketresearch.com/market-research/robotic-surgery-market.asp

Veterinary Teleradiology Market
https://www.persistencemarketresearch.com/market-research/veterinary-teleradiology-market.asp

Dental Radiology Equipment Market
https://www.persistencemarketresearch.com/market-research/dental-radiology-equipment-market.asp

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.